Showing 1 - 10 of 12
that entry and exit rates are positively correlated across industries. Our objective is to investigate the effect of sunk … costs and, in particular, market size on entry and exit rates. We analyse a stochastic dynamic model of a monopolistically … show existence and uniqueness of a stationary equilibrium with simultaneous entry and exit: efficient firms survive while …
Persistent link: https://www.econbiz.de/10005136712
We analyse productivity growth in UK manufacturing 1980-92 using the newly available ARD panel of establishments drawn from the Census of Production. We examine the relative importance of 'internal' restructuring (such as new technology and organizational change) and 'external' restructuring...
Persistent link: https://www.econbiz.de/10005666830
within a region, explicitly taking into account exit, as well as entry, costs. Protecting workers by having strict lay … influence the entry decision? …
Persistent link: https://www.econbiz.de/10005656365
In this paper we discuss determinants of firm survival and growth in Germany within its pre-1989 boundaries. We argue that the legal form adopted by a firm is an important indicator of the riskiness of projects undertaken, and that firms under limited liability should be characterized by higher...
Persistent link: https://www.econbiz.de/10005136761
Objective: We estimate the effects of Reference Pricing, a drug cost control policy introduced by the BC Ministry of Health Pharmacare program in 1995, on its program expenditures for seniors, out of pocket costs paid by its senior beneficiaries, indicators of beneficiary health status and...
Persistent link: https://www.econbiz.de/10005763258
(see SEDAP 70 for abstract)
Persistent link: https://www.econbiz.de/10005763264
The 1984 Canada Health Act does not require that the provinces subsidize prescription drugs. Many provinces do, however, provide categorical coverage to the elderly, social assistance recipients and others, although the generosity of coverage is highly variable. A system of parallel private...
Persistent link: https://www.econbiz.de/10005763326
(see QSEP 369 for abstract)
Persistent link: https://www.econbiz.de/10005181106
Objective: We estimate the effects of Reference Pricing, a drug cost control policy introduced by the BC Ministry of Health Pharmacare program in 1995, on its program expenditures for seniors, out of pocket costs paid by its senior beneficiaries, indicators of beneficiary health status and...
Persistent link: https://www.econbiz.de/10005181109
(see QSEP 369 for abstract)
Persistent link: https://www.econbiz.de/10005181110